Trial ID: | L0795 |
Source ID: | IRCT20180513039634N1
|
Associated Drug: |
Crocin
|
Title: |
Evaluation of the effect of Crocin on the serum levels of liver enzymes and Lipid Profile in patients with non-alcoholic fatty liver disease
|
Acronym: |
--
|
Status: |
Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
non-alcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified
|
Interventions: |
Intervention 1: Intervention group: receiving one tablet containing 15 mg of Crocin (Samisaz Pharmaceutical Co.) daily with meal for 8 weaks. Intervention 2: Control group: receiving one tablet placebo (maltodextrin) daily with meal for 8 weaks.
|
Outcome Measures: |
ALT. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzymatic photometery.;AST. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzymatic photometery.;TC, TG, LDL, HDL. Timepoint: Before intervention and 8 weak after intervention. Method of measurement: Enzymatic photometry.nan
|
Sponsor/Collaborators: |
Ahvaz University of Medical Sciences
|
Gender: |
All
|
Age: |
18 yearsno limit
|
Phases: |
Phase 3
|
Enrollment: |
60
|
Study Type: |
interventional
|
Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization, Blinding description: To maintain the double-blinded condition of the study design, labeled stud
|
Start Date: |
13/06/2018
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
16 July 2018
|
Locations: |
Iran (Islamic Republic of)
|
URL: |
http://en.irct.ir/trial/31115
|